Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-17

Clinical Trial Update: Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy [NA]

View source ↗

Summary

A completed trial update on restoring vision with the Intelligent Retinal Implant System (IRIS V1) in patients with retinal dystrophy, including retinitis pigme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intelligent Retinal Implant System (IRIS V1)

Snippet

Sponsor: Science Corporation | Conditions: Retinitis Pigmentosa, Cone Rod Dystrophy | NA | Status: COMPLETED